Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO
· Real-Time Price · USD
5.26
-0.23 (-4.19%)
At close: May 09, 2025, 3:59 PM
5.31
0.95%
After-hours: May 09, 2025, 07:38 PM EDT
Abeona Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|
| License and Other Revenues Revenue | 3M | 10M |
| License and Other Revenues Revenue Growth | -70.00% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.68M | 6.4M | 8.65M | 6.4M | 5.11M | 3.44M | 5.76M | 3.11M | 5.68M | 3.89M | 3.46M | 4.22M | 4.68M | 6.09M | 5.46M | 6.57M | 7.4M | 4.43M | 5.54M | 6.41M | 4.73M | 4.7M | 5.61M | 5.66M | 7.63M | 4.97M | 4.63M | 2.88M | 3.11M | 2.17M | 2.64M | 3.02M | 2.8M | 2.39M | 3.73M | 4.37M | 4.25M | 4.72M | 3.67M | 1.69M |
| Selling, General, and Administrative Revenue Growth | +19.89% | -25.93% | +35.11% | +25.25% | +48.73% | -40.34% | +85.20% | -45.28% | +46.07% | +12.43% | -18.09% | -9.71% | -23.21% | +11.64% | -16.92% | -11.21% | +66.90% | -19.97% | -13.63% | +35.45% | +0.72% | -16.25% | -0.83% | -25.84% | +53.54% | +7.41% | +60.77% | -7.55% | +43.72% | -18.02% | -12.57% | +7.81% | +17.23% | -35.90% | -14.57% | +2.80% | -9.96% | +28.63% | +117.11% | n/a |
| Research and Development Revenue | 8.99M | 8.94M | 9.22M | 7.21M | 7.38M | 7.15M | 8.52M | 8.04M | 6.27M | 5.49M | 6.66M | 10.54M | 11.7M | 7.98M | 7.43M | 7.21M | 9.24M | 7.97M | 6.11M | 6.82M | 9.61M | 10.92M | 16.31M | 11.74M | 9.47M | 13.15M | 7.92M | 8.16M | 5.71M | 3.28M | 5.81M | 2.2M | 3.04M | 2.75M | 3.02M | 1.85M | 2.07M | 1.58M | 610K | 453K |
| Research and Development Revenue Growth | +0.59% | -3.00% | +27.90% | -2.33% | +3.23% | -16.13% | +5.99% | +28.20% | +14.24% | -17.54% | -36.86% | -9.88% | +46.67% | +7.32% | +3.08% | -21.97% | +15.99% | +30.45% | -10.40% | -29.02% | -12.02% | -33.05% | +38.94% | +23.94% | -27.98% | +66.12% | -3.01% | +43.04% | +74.12% | -43.58% | +164.24% | -27.63% | +10.64% | -9.05% | +62.70% | -10.43% | +30.99% | +159.18% | +34.66% | n/a |